Global Hyperhidrosis Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Hyperhidrosis Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Hyperhidrosis Treatment market size was valued at USD 1339.7 million in 2022 and is forecast to a readjusted size of USD 1913.6 million by 2029 with a CAGR of 5.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global top 5 players of hyperhidrosis treatment include Allergan (AbbVie), GlaxoSmithKline, Cynosure, Journey Medical Corporation and miraDry. As the largest player, Allergan (AbbVie) makes up over a quarter.

North America ranks first in terms of market size by region, making up around 35%, followed by Europe and Asia-Pacific.

Based on the product type, the hyperhidrosis treatment is primarily split into medications, surgical treatments and physiotherapy, etc. Among them, medical is the largest segment, with a share over 45%.

Hyperhidrosis treatment is mainly used for primary focal hyperhidrosis and secondary generalized hyperhidrosis, in which the former one dominates with a share over 60%.

In some people, the body’s mechanism for cooling itself is overactive — so overactive that they may sweat four or five times more than is necessary, or normal. When sweating is this extreme it can be embarrassing, uncomfortable, anxiety-inducing, dangerous, and disabling. It often disrupts all aspects of a person's life, from career choices and recreational activities to relationships, emotional well-being, and self-confidence. This kind of excessive sweating is a serious medical condition. It's called hyperhidrosis and it afflicts millions of people around the world (nearly 5% of the world's population). But, due to lack of awareness among sufferers and lack of education among medical professionals, most people are never diagnosed or relieved of their symptoms.

This report is a detailed and comprehensive analysis for global Hyperhidrosis Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Hyperhidrosis Treatment market size and forecasts, in consumption value ($ Million), 2018-2029

Global Hyperhidrosis Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Hyperhidrosis Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Hyperhidrosis Treatment market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Hyperhidrosis Treatment

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Hyperhidrosis Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan (AbbVie), GlaxoSmithKline, Cynosure, Journey Medical Corporation and miraDry, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Hyperhidrosis Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Medications
Surgical Treatments
Physiotherapy

Market segment by Application
Primary Focal Hyperhidrosis
Secondary Generalized Hyperhidrosis

Market segment by players, this report covers
Allergan (AbbVie)
GlaxoSmithKline
Cynosure
Journey Medical Corporation
miraDry
Alma Lasers
Carpe
Duradry
Merz Ultherapy
Fotona
BTXA
Seaford Pharmaceuticals
Robugen GmbH

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Hyperhidrosis Treatment product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Hyperhidrosis Treatment, with revenue, gross margin and global market share of Hyperhidrosis Treatment from 2018 to 2023.

Chapter 3, the Hyperhidrosis Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hyperhidrosis Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Hyperhidrosis Treatment.

Chapter 13, to describe Hyperhidrosis Treatment research findings and conclusion.